Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
6.34
+0.07 (1.12%)
At close: Jun 12, 2026, 4:00 PM EDT
6.35
0.00 (0.08%)
After-hours: Jun 12, 2026, 4:10 PM EDT

Journey Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
175209871113493
Market Cap Growth
-7.14%141.61%-22.18%226.31%-63.39%-
Enterprise Value
172.82210.5991.498.625.0744.99
Last Close Price
6.347.713.915.761.925.38
Forward PE
42.9861.68----
PS Ratio
2.703.381.541.410.461.48
PB Ratio
5.626.574.325.472.012.22
P/TBV Ratio
37.3944.47-1666.97-1.86
P/FCF Ratio
---21.24--
P/OCF Ratio
---21.24--
EV/Sales Ratio
2.673.401.631.250.340.71
EV/EBITDA Ratio
---55.33--
EV/FCF Ratio
---18.82--
Debt / Equity Ratio
0.740.791.250.721.350.02
Debt / EBITDA Ratio
---8.27--
Debt / FCF Ratio
---2.81--
Net Debt / Equity Ratio
-0.060.040.24-0.62-0.53-1.15
Net Debt / EBITDA Ratio
0.91-0.34-0.47-7.130.391.49
Net Debt / FCF Ratio
4.21-0.10-0.52-2.420.6722.09
Asset Turnover
0.530.710.710.870.730.85
Inventory Turnover
2.361.741.691.882.565.70
Quick Ratio
1.381.440.871.020.901.40
Current Ratio
1.721.791.371.351.161.64
Return on Equity (ROE)
-30.59%-44.03%-72.60%-20.64%-100.39%-168.13%
Return on Assets (ROA)
-6.86%-9.40%-17.49%-2.42%-27.24%-48.56%
Return on Invested Capital (ROIC)
-20.43%-24.87%-48.72%-7.17%-98.48%-183.47%
Return on Capital Employed (ROCE)
-11.44%-15.99%-34.17%-5.66%-65.52%-100.35%
FCF Yield
---4.71%--
Buyback Yield / Dilution
-21.41%-19.90%-12.06%-4.00%-72.15%6.02%
Total Shareholder Return
-21.41%-19.90%-12.06%-4.00%-72.15%6.02%
SEC Filings: 10-K · 10-Q